The HPS treatment significantly increased the phosphorylation levels of PKC-α and PKC-δ (p < 0.01), and the protein levels of PKC-α and PKC-δ did not significantly change. The gene discussed is PRKCA; the disease is Hermansky-Pudlak syndrome.